OncoMatch/Clinical Trials/NCT03025477
Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer
Is NCT03025477 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies multiple treatments including CC0 - Carboplatin (IV) - Paclitaxel (IV) and CC0 - Cisplatin (IP) - Epirubicin (IV) for ovarian cancer, epithelial.
Treatment: CC0 - Carboplatin (IV) - Paclitaxel (IV) · CC0 - Cisplatin (IP) - Epirubicin (IV) · CC>0 - Carboplatin (IV)- Paclitaxel (IV) · CC>0 - Cisplatin (IP/IV)- Epirubicin (IV) — CHIMOVIP is a study to determine the best therapeutic strategy in patient with ovarian advanced cancer.
Check if I qualifyExtracted eligibility criteria
Treatments studied
Chemotherapy
Cancer type
Ovarian Cancer
Disease stage
Required: Stage FIGO STAGE III, FIGO STAGE IV (FIGO)
Excluded: Stage FIGO STAGE IV EXTRA-ABDOMINAL DISEASE
Metastatic disease required
advanced (FIGO stage III or IV)... Exclusion: FIGO stage IV extra-abdominal disease, with the exception of lymph nodes and pleural invasion
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Demographics
Prior therapy
Cannot have received: chemotherapy
Lab requirements
Blood counts
neutrophils > 1500/mm3, platelets > 150 000/mm3
Kidney function
creatinine clearance mdrd ≥ 60 ml/min
Cardiac function
left ventricular ejection fraction ≥ 50% before chemotherapy initiation
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT03025477 currently recruiting?
Yes, this trial is currently recruiting patients.
Can patients have received prior systemic therapy?
No. This trial requires treatment-naive patients — prior systemic therapy is an exclusion criterion.
What disease stage is eligible?
Stage FIGO STAGE III or FIGO STAGE IV is required (metastatic disease required).
Is there an age limit?
Yes. Patients must be 75 years or younger.
Is this trial open to male patients?
No. This trial enrolls female patients only.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages